Company
Headquarters: Taipei, Taiwan
TW$6.08 Billion
TWD as of July 1, 2024
US$186.7 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan, China, and Japan. It offers dialyzers, dialysis and RO machines, and relative consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products. The company also engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks. In addition, it provides hemodialysis management services; and operates as an OEM supplier for beverage raw materials and concentrates. The company was founded in 1989 and is headquartered in Taipei, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Hi-Clearance, Inc. has the following listings and related stock indices.
Stock: TWSE: 1788 wb_incandescent